Table 3. Univariate analysis, with numbers eligible for analysis.
|
Breast
|
Colorectal
|
Prostate
|
||||
|---|---|---|---|---|---|---|
| Survivor | Control | Survivor | Control | Survivor | Control | |
| Screening exam | ||||||
| Mammogram | 54.4% | 59.5% | 60.5% | 58.5% | ||
| Number in analysis | 2317 | 9974 | 513 | 2055 | — | — |
| Cervical smear | ||||||
| Aged 25–49 years | 43.6% | 40.1% | 13.9% | 15.2% | — | — |
| Number in analysis | 755 | 3085 | 65 | 263 | ||
| Aged 50–64 years | 45.7% | 44.4% | 41.6% | 41.9% | — | — |
| Number in analysis | 3419 | 14 061 | 178 | 855 | ||
| PSA test | — | — | 22.1% | 19.0% | — | — |
| Number in analysis | 2489 | 9859 | ||||
| Preventative health | ||||||
| Influenza vaccination | 75.8% | 74.4% | 74.9% | 73.2% | 74.6% | 70.2% |
| Number in analysis | 9488 | 37 803 | 4118 | 16 325 | 3854 | 15 275 |
| Blood pressure | 68.0% | 69.2% | 70.1% | 70.4% | 70.7% | 68.7% |
| Number in analysis | 9771 | 38 815 | 2531 | 10 668 | 2105 | 9252 |
| Bone density scan | 14.1% | 10.3% | 13.2% | 10.5% | 17.1% | 9.3% |
| Number in analysis | 14 574 | 59 471 | 4455 | 17 954 | 3928 | 16 026 |
| Cholesterol test | 31.9% | 33.1% | 37.8% | 36.2% | 39.9% | 36.7% |
| Number in analysis | 9072 | 35311 | 2306 | 9235 | 1720 | 7563 |
Abbreviation: PSA=prostate-specific antigen.